DHR · XBRL financial data

Danaher financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (DHR's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 27, 2026	Q2 FY26Jun 26, 2026	Q3 FY26Sep 25, 2026
Revenue from contracts with customers	6,405	5,796	5,743	5,798	6,538*	5,741	5,936	6,053	6,838*	5,951	6,265	6,554
Cost of goods and services sold	1,070*	2,309	2,315	2,397	2,648*	2,230	2,413	2,530	2,872*	2,360	2,654	2,717
Gross profit	3,779	3,487	3,428	3,401	—	3,511	3,523	3,523	—	3,591	3,611	3,837
Research and development	239*	368	391	383	442*	379	403	378	438*	387	412	433
Selling, general and administrative	843*	1,807	1,869	2,060	2,023*	1,858	2,360	1,991	2,026*	1,860	2,072	2,159
Operating income (loss)	1,337	1,312	1,168	958	1,425*	1,274	760	1,154	1,502*	1,344	1,127	1,245
Interest income	117*	60	39	4	14*	6	8	3	13*	27	61	31
Interest expense	78*	65	65	87	61*	72	71	67	55*	63	107	135
Other income (expense)	(123)*	(36)	(59)	102	(63)*	(79)	(42)	(14)	(87)*	(73)	(3)	(9)
Income tax expense (benefit)	(79)*	183	176	159	229*	175	100	168	190*	206	208	(75)
Net income (loss)	1,079*	1,088	907	818	1,086*	954	555	908	1,197*	1,029	870	1,235
Earnings per share, basic USD per share	1.46	1.47	1.23	1.13	1.50*	1.33	0.77	1.28	1.69*	1.45	1.23	1.75
Earnings per share, diluted USD per share	1.45	1.45	1.22	1.12	1.49*	1.32	0.77	1.27	1.68*	1.45	1.23	1.75
Weighted average shares, basic millions of shares	740*	741	738	723	723*	716	717	711	708*	708	705	704
Weighted average shares, diluted millions of shares	745*	749	742	729	729*	721	719	714	711*	711	708	707

Balance sheet

CSV

Fiscal quarters (DHR's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 27, 2026	Q2 FY26Jun 26, 2026	Q3 FY26Sep 25, 2026
Cash and cash equivalents	5,864	7,031	2,374	2,627	2,078	1,993	2,957	1,528	4,615	5,701	4,348	5,682
Accounts receivable	3,922	3,379	3,298	3,507	3,537	3,506	3,564	3,755	3,913	3,819	3,965	4,126
Inventory	2,594	2,645	2,671	2,678	2,330	2,532	2,689	2,674	2,489	2,608	3,260	3,134
Prepaid and other current assets	1,557	1,317	1,266	1,248	1,552	1,494	1,789	1,649	1,739	1,807	1,808	1,845
Total current assets	13,937	14,372	9,609	10,060	9,497	9,525	10,999	9,606	12,756	13,935	13,381	14,787
Property and equipment, net	4,553	4,562	4,643	4,843	4,990	5,110	5,309	5,376	5,531	5,468	5,825	5,773
Right-of-use asset	1,052	1,100	1,100	1,200	1,084	1,100	1,100	1,200	1,214	1,200	1,200	1,200
Goodwill	41,608	40,846	40,805	42,173	40,497	41,657	42,991	42,948	43,151	42,765	47,414	47,315
Total assets	84,488	83,402	78,555	80,615	77,542	79,116	81,620	79,897	83,464	83,544	92,367	93,281
Accrued liabilities	4,813	4,353	4,355	4,543	4,540	4,422	4,565	4,603	4,961	4,747	4,872	5,214
Total current liabilities	8,274	7,778	6,701	7,339	6,798	6,645	6,792	6,324	6,807	7,460	8,105	9,050
Long-term debt	16,707	16,417	16,309	16,324	15,500	15,976	16,853	16,833	18,416	17,561	25,147	24,388
Lease liability, non-current	954	—	—	—	968	—	—	—	1,079	—	—	—
Retained earnings	41,074	41,962	42,673	43,296	44,188	44,913	45,239	45,920	46,891	47,637	48,226	49,179
Total stockholders' equity	53,486	53,442	49,897	51,299	49,543	50,849	52,334	51,071	52,534	52,949	52,581	53,621
Total liabilities and equity	84,488	83,402	78,555	80,615	77,542	79,116	81,620	79,897	83,464	83,544	92,367	93,281
Common shares outstanding (cover page) millions of shares	740	741	722	722	715	716	716	706	707	708	703	704

Cash flows

CSV

Fiscal quarters (DHR's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 29, 2024	Q2 FY24Jun 28, 2024	Q3 FY24Sep 27, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 28, 2025	Q2 FY25Jun 27, 2025	Q3 FY25Sep 26, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 27, 2026	Q2 FY26Jun 26, 2026	Q3 FY26Sep 25, 2026
Net income (loss)	1,079*	1,088	907	818	1,086*	954	555	908	1,197*	1,029	870	1,235
Stock-based compensation	26*	60	87*	84*	57*	61	91*	83*	63*	58	93*	115*
Depreciation and amortization	year only	—	—	—	—	—	—	—	—	—	—	—
Net cash from operating activities	1,619*	1,739	1,417*	1,513*	2,019*	1,299	1,338*	1,662*	2,117*	1,322	1,534*	1,886*
Purchases of property and equipment	402*	291	287*	298*	516*	245	248*	292*	371*	237	269*	255*
Net cash from investing activities	(6,017)*	(321)	(360)*	(606)*	(694)*	(242)	(258)*	(312)*	(384)*	(249)	(10,147)*	(300)*
Share repurchases	0*	0	4,530*	640*	809*	1,078	0*	2,010*	0*	0	894*	0*
Dividends paid	200*	177	200*	196*	195*	194	229*	229*	226*	226	283*	281*
Net cash from financing activities	(2,246)*	(133)	(5,715)*	(845)*	(1,692)*	(1,255)	(247)*	(2,781)*	1,322*	46	7,273*	(262)*
Net change in cash	(6,413)*	1,167	(4,657)*	253*	(549)*	(85)	964*	(1,429)*	3,087*	1,086	(1,353)*	1,334*

Compare with peers

SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Danaher	5,682	6,554	1,886*	703.5M	Q3 FY26 10-QSep 25, 2026
Thermo Fisher Scientific	5,461	12,137	2,550*	370.5M	Q3 FY26 10-QSep 26, 2026
KLA	1,532	4,136	1,531	1.3B	Q1 FY27 10-QSep 30, 2026
Trane Technologies	not reported	6,760	1,313*	218.9M	Q3 FY26 10-QSep 30, 2026
Roper Technologies	311	2,172	821*	99.0M	Q3 FY26 10-QSep 30, 2026
Ametek	666	2,220	561*	229.3M	Q3 FY26 10-QSep 30, 2026
Coherent	1,162	2,046*	69*	195.8M	Q4 FY26 10-KJun 30, 2026
Rockwell Automation	479	2,313	724*	111.0M	Q3 FY26 10-QJun 30, 2026
Agilent Technologies	1,758	1,878	519*	281.9M	Q3 FY26 10-QJul 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.